All In. All Ways.

Baxter’s commitment to saving and sustaining lives has grown to impact many areas of healthcare. With ongoing investments in world-class manufacturing, meaningful innovations and a focus on patient safety, Baxter prioritizes patients and healthcare providers by ensuring that innovative treatment, solutions and support are available to help enhance safety and improve patient care. We're All In, All Ways.

Healthcare professionals wearing masks have a discussion around a conference table

Hillrom is Now a Part of Baxter

Baxter and Hillrom are uniting to meet the challenges of a rapidly-evolving healthcare landscape. Together, we will work to enable care efficiencies, improve care outcomes and broaden access to care at home, in the hospital, and in alternate sites of care.

As we progress our integration, we are focused on maintaining business continuity for you and your patients. There are no immediate changes to current ordering, invoicing and payment processes, technical service, clinical support or other services for either Baxter or Hillrom customers. We pledge to frequently and transparently provide updates as our service and support evolve throughout the integration.

Heather Knight

Advancing the Next Generation of Transformative Healthcare

“Together, Baxter and Hillrom can unlock smarter solutions and efficiencies for providers that support improvements in clinical decision-making, care outcomes and other areas critical for patient care.”

Heather Knight, President, Medication Delivery, Acute Therapies, Clinical Nutrition, Latin America and Canada

Bortezomib Product

Recent launch:
A generic Bortezomib for Injection is available at a sustainable price.

Learn more about Bortezomib
Norepinephrine Bitartrate in 5% Dextrose Injection

Premix: Norepinephrine Bitartrate in 5% Dextrose Injection

Learn more about Norepinephrine

Partnering with You to Help Solve Today’s Challenges

 

A retrospective study estimated there are 1.2 million hospitalizations with preventable adverse drug events (ADE) related to injectable medications. Incremental cost of all preventable ADEs is estimated to be $3.8 billion annually.1

 

A retrospective study to assess the impact of the drug delivery system on the odds of bloodstream infection (BSI) showed a 12% reduction in odds of BSI with closed systems.2

 

Intravenous medication preparation is a complex process, with 30% of hospitals experiencing a patient event involving a compounding error over a five-year period.3

Partnering for Better Outcomes from the Bedside to the Pharmacy

Male doctor talking to a male patient lying in a hospital bed

For 90 years, Baxter has been saving and sustaining lives. We take pride in our ability to help maximize the quality, safety, and ease of use of our products and medications, while minimizing costs, all in pursuit of helping you achieve the best outcomes for your patients.

Where You Need Us Most in the Healthcare System

Contributing to Peace of Mind

Close up on a hospital pharmacist's face with scrubs and hair covered

Our robust manufacturing and distribution network helps ensure continuity of supply to contribute to peace of mind for clinicians that they will have product when it’s needed.

Our worldwide manufacturing footprint allows us to source quality medical products for the U.S.

 

Our IV solutions facility in North Cove, NC, manufactures more than 125 different solutions.

 

Our IV solutions plant in Puerto Rico is one of the largest IV solutions manufacturing facilities in the world.

 

We increased U.S. capacity through our extensive global manufacturing operations in 2018.

For Medical Information, please access US Medical Information On-line.